FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081838961> ?p ?o ?g. }

• W3081838961 endingPage "026" @default.
• W3081838961 startingPage "015" @default.
• W3081838961 abstract "Fucosylated chondroitin sulfate (FCS) polysaccharide isolated from sea cucumber has potent anticoagulant activity. Based on its resistance to the enzymes present in vertebrates, it may serve as an anticoagulant and shows antithrombotic effects when delivered through gastro-resistant (GR) tablets. However, due to the multiple plasma targets of FCS polysaccharide in the coagulation pathway, bleeding can occur after its oral administration. In the current study, we used FCS oligomers, in particular a mixture of oligosaccharides having 6 to 18 saccharide units, as the active ingredient in GR microcapsules for oral anticoagulation. In a Caco-2 model, the FCS oligomers showed higher absorption than native FCS polysaccharides. Oral administration of FCS oligomer-GR microcapsules provided a dose-dependent, prolonged anticoagulant effect with a selective inhibition of the intrinsic coagulation pathway when compared with subcutaneous administration of FCS oligomers or oral administration of unformulated FCS oligomers or native FCS-GR microspheres. Continued oral administration of FCS oligomer-GR microcapsules did not result in the accumulation of oligosaccharides in the plasma. Venous thrombosis animal models demonstrated that FCS oligomers delivered via GR microcapsules produced a potent antithrombotic effect dependent on their anticoagulant properties in the plasma, while oral administration of unformulated FCS oligomers at the same dose exhibited a weaker antithrombotic effect than the formulated version. Oral administration of FCS oligomer-GR microcapsules resulted in no bleeding, while oral administration of native FCS-GR microcapsules resulted in bleeding (p < 0.05). Our present results suggest that a FCS oligomer-GR microcapsule formulation represents an effective and safe oral anticoagulant for potential clinical applications." @default.
• W3081838961 created "2020-09-08" @default.
• W3081838961 creator A5029064402 @default.
• W3081838961 creator A5040353743 @default.
• W3081838961 creator A5056210370 @default.
• W3081838961 creator A5060124320 @default.
• W3081838961 creator A5069724772 @default.
• W3081838961 creator A5071958350 @default.
• W3081838961 creator A5089613337 @default.
• W3081838961 creator A5090638283 @default.
• W3081838961 date "2020-08-30" @default.
• W3081838961 modified "2023-10-18" @default.
• W3081838961 title "Oral Administration of Fucosylated Chondroitin Sulfate Oligomers in Gastro-Resistant Microcapsules Exhibits a Safe Antithrombotic Activity" @default.
• W3081838961 cites W1507206095 @default.
• W3081838961 cites W1806451165 @default.
• W3081838961 cites W1970245984 @default.
• W3081838961 cites W1970445147 @default.
• W3081838961 cites W1972468298 @default.
• W3081838961 cites W2013710547 @default.
• W3081838961 cites W2015449015 @default.
• W3081838961 cites W2022840798 @default.
• W3081838961 cites W2049925496 @default.
• W3081838961 cites W2050532277 @default.
• W3081838961 cites W2057066738 @default.
• W3081838961 cites W2058844726 @default.
• W3081838961 cites W2070112905 @default.
• W3081838961 cites W2077114316 @default.
• W3081838961 cites W2079487514 @default.
• W3081838961 cites W2080127961 @default.
• W3081838961 cites W2096869177 @default.
• W3081838961 cites W2133686162 @default.
• W3081838961 cites W2134430286 @default.
• W3081838961 cites W2159407715 @default.
• W3081838961 cites W2159631961 @default.
• W3081838961 cites W2160274832 @default.
• W3081838961 cites W2171713512 @default.
• W3081838961 cites W2338618131 @default.
• W3081838961 cites W2340428934 @default.
• W3081838961 cites W2523217755 @default.
• W3081838961 cites W2578519736 @default.
• W3081838961 cites W2585802353 @default.
• W3081838961 cites W2609260476 @default.
• W3081838961 cites W2755016866 @default.
• W3081838961 cites W2775402656 @default.
• W3081838961 cites W2798017470 @default.
• W3081838961 cites W2956158307 @default.
• W3081838961 cites W2965317454 @default.
• W3081838961 cites W2023585844 @default.
• W3081838961 cites W2162130052 @default.
• W3081838961 doi "https://doi.org/10.1055/s-0040-1714738" @default.
• W3081838961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32862408" @default.
• W3081838961 hasPublicationYear "2020" @default.
• W3081838961 type Work @default.
• W3081838961 sameAs 3081838961 @default.
• W3081838961 citedByCount "6" @default.
• W3081838961 countsByYear W30818389612021 @default.
• W3081838961 countsByYear W30818389612022 @default.
• W3081838961 crossrefType "journal-article" @default.
• W3081838961 hasAuthorship W3081838961A5029064402 @default.
• W3081838961 hasAuthorship W3081838961A5040353743 @default.
• W3081838961 hasAuthorship W3081838961A5056210370 @default.
• W3081838961 hasAuthorship W3081838961A5060124320 @default.
• W3081838961 hasAuthorship W3081838961A5069724772 @default.
• W3081838961 hasAuthorship W3081838961A5071958350 @default.
• W3081838961 hasAuthorship W3081838961A5089613337 @default.
• W3081838961 hasAuthorship W3081838961A5090638283 @default.
• W3081838961 hasConcept C100817775 @default.
• W3081838961 hasConcept C126322002 @default.
• W3081838961 hasConcept C178790620 @default.
• W3081838961 hasConcept C185592680 @default.
• W3081838961 hasConcept C2777015399 @default.
• W3081838961 hasConcept C2777056448 @default.
• W3081838961 hasConcept C2778205648 @default.
• W3081838961 hasConcept C2778382381 @default.
• W3081838961 hasConcept C2780642029 @default.
• W3081838961 hasConcept C55493867 @default.
• W3081838961 hasConcept C71924100 @default.
• W3081838961 hasConcept C98274493 @default.
• W3081838961 hasConceptScore W3081838961C100817775 @default.
• W3081838961 hasConceptScore W3081838961C126322002 @default.
• W3081838961 hasConceptScore W3081838961C178790620 @default.
• W3081838961 hasConceptScore W3081838961C185592680 @default.
• W3081838961 hasConceptScore W3081838961C2777015399 @default.
• W3081838961 hasConceptScore W3081838961C2777056448 @default.
• W3081838961 hasConceptScore W3081838961C2778205648 @default.
• W3081838961 hasConceptScore W3081838961C2778382381 @default.
• W3081838961 hasConceptScore W3081838961C2780642029 @default.
• W3081838961 hasConceptScore W3081838961C55493867 @default.
• W3081838961 hasConceptScore W3081838961C71924100 @default.
• W3081838961 hasConceptScore W3081838961C98274493 @default.
• W3081838961 hasIssue "01" @default.
• W3081838961 hasLocation W30818389611 @default.
• W3081838961 hasLocation W30818389612 @default.
• W3081838961 hasOpenAccess W3081838961 @default.
• W3081838961 hasPrimaryLocation W30818389611 @default.
• W3081838961 hasRelatedWork W1929072719 @default.
• W3081838961 hasRelatedWork W1976945395 @default.
• W3081838961 hasRelatedWork W2000974497 @default.

• next